A Phase 1/2 Trial of CBL0137 (NSC# 825802, IND# 155843
Clinical Trial Grant
Administered By
Pediatrics, Hematology-Oncology
Awarded By
Public Health Institute
Start Date
November 14, 2025
End Date
June 15, 2030
Administered By
Pediatrics, Hematology-Oncology
Awarded By
Public Health Institute
Start Date
November 14, 2025
End Date
June 15, 2030